The overexpression of CD24 has been documented in several tumor types and the activation of the CD24/Siglec-10 axis has been shown to promote tumor immune evasion through the suppression of the cytotoxic T cell function and macrophage-mediated phagocytosis. Here, CD24 is linked to neoplasm.